Rentokil Initial plc
NYSE:RTOSpecialty Business Services
-$1.31 today
- Market cap
- $11.86B
- Beta
- 0.42
- P/E (TTM)
- 35.4
- EPS (TTM)
- $0.12
- Dividend yield
- 2.15%
Volume 1.08M
Average 0.99M
RTO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Rentokil Initial plcNYSE: RTO
EBITDA · Q4 FY2025 · quarter ended Dec 2025
EBITDA grows 63.7% year over year
Q4 FY2025 EBITDA of $761.07M rose 63.7% year over year. Over 3 fiscal years it compounded at +26.4% a year.
Context
- EBITDA amounted to 21.8% of revenue in FY2025, up 3.6 pp from a year earlier.
- EBITDA increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 12 analysts of $1.09B (-27.7%) for the fiscal year ending Dec 2026, a slowdown from the +52.5% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterDec 2025
- $761.07M— QoQ
- Last fiscal yearDec 2025
- $1.51B+52.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +63.7% | — | — |
| 1 year | +52.5% | -27.7% | -80.2 pp |
| 3-year CAGR | +26.4% | -7.8% | -34.2 pp |
| 5-year CAGR | -3.2% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
Mixed currencies · from the income statement
- Latest · FY2025
- 1.51B USD
- Year-over-year change
- —
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.51B | — |
| FY2024 | 2024-12-31 | 990M | -14.4% |
| FY2023 | 2023-12-31 | 1.16B | +54.7% |
| FY2022 | 2022-12-31 | 748M | +29.0% |
| FY2021 | 2021-12-31 | 580M | — |
EBITDA vs competitors
How RTO compares with its peers on the latest reported figures
- RTO's FY2025 EBITDA of $1.51B is the 3rd highest of the 6 companies compared; the peer median is $1.46B.
- Its year-over-year change of +52.5% is the highest of 6, against a peer median of +2.4%.
- EBITDA amounts to 21.8% of revenue for RTO, versus a peer median of 21.4%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $3.6B | -8.7% | +10.8% | 21.4% | |
| LTM Aug 2026 | $3.22B | +10.2% | +12.0% | 27.8% | |
| FY2025 | $1.51B | +52.5% | +26.4% | 21.8% | |
| LTM Oct 2026 | $1.46B | +16.7% | +0.2% | 7.3% | |
| LTM Sep 2026 | $861.45M | +2.4% | +12.9% | 21.6% | |
| LTM Aug 2026 | $284.07M | -15.4% | +3.0% | 11.3% | |
| Peer median (excluding RTO) | $1.46B | +2.4% | +10.8% | 21.4% | |
Competitors are the stored peer set for RTO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 · GBP | FY2022 Dec 2022 · GBP | FY2023 Dec 2023 · GBP | FY2024 Dec 2024 · GBP | FY2025 Dec 2025 · USD |
|---|---|---|---|---|---|
| Revenue | 2.95B | 3.71B | 5.38B | 5.44B | 6.91B |
| Cost of Revenue | 596M | 704M | 927M | 4.71B | 4.66B |
| Gross Profit | 728.72M | 3.01B | 4.45B | 726M | 2.27B |
| Gross Margin | 24.7% | 81.0% | 82.8% | 13.4% | 32.8% |
| Research & Development | 5M | 5M | 0 | 7M | 0 |
| Selling, General & Admin | 348.6M | 479M | 2.87B | 0 | 0 |
| Operating Expenses | 2.01B | 2.69B | 3.82B | 177M | 1.32B |
| Depreciation & Amortization | 202M | 258M | 475M | 320M | 563.53M |
| EBITDA | 580M | 748M | 1.16B | 990M | 1.51B |
| EBITDA Margin | 19.6% | 20.1% | 21.5% | 18.2% | 21.8% |
| Operating Income | 347M | 317M | 625M | 549M | 945.89M |
| Operating Margin | 11.7% | 8.5% | 11.6% | 10.1% | 13.7% |
| Interest Income | 1M | 5M | 25M | 36M | 31.03M |
| Interest Expense | 34M | 77M | 189M | 192M | 60.06M |
| Other Income / Expenses | (22M) | (21M) | (132M) | (144M) | (555.52M) |
| Income Before Tax | 325M | 296M | 493M | 405M | 390.37M |
| Pre-Tax Margin | 11.0% | 8.0% | 9.2% | 7.5% | 5.6% |
| Income Tax Expense | 61.9M | 64M | 112M | 98M | 100.09M |
| Net Income | 263M | 232M | 381M | 307M | 470.44M |
| Net Margin | 8.9% | 6.2% | 7.1% | 5.6% | 6.8% |
| EPS (Basic) | 0.70 | 0.60 | 0.75 | 0.60 | 0.95 |
| EPS (Diluted) | 0.70 | 0.60 | 0.75 | 0.60 | 0.95 |
| Weighted Avg Shares | 371.62M | 400.4M | 503.2M | 505.77M | 504.8M |
| Weighted Avg Shares (Diluted) | 373.26M | 402.8M | 505.4M | 505.6M | 507M |
Rentokil Initial plc
NYSE:RTO
Intrinsic Alpha fair value
Locked
Current Price
$23.58
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.